OCULAR MANIFESTATIONS IN A PATIENT WITH HIDRADENITIS SUPPURATIVA: A CASE STUDY.

Q4 Medicine
Georgian medical news Pub Date : 2025-01-01
H Al Dhaheri, M Khan
{"title":"OCULAR MANIFESTATIONS IN A PATIENT WITH HIDRADENITIS SUPPURATIVA: A CASE STUDY.","authors":"H Al Dhaheri, M Khan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with chronic inflammatory skin disease called hidradenitis suppurativa (HS), which can also produce systemic comorbidities, show ocular symptoms. Although HS has dermatological roots, if left untreated it can cause major ocular issues like dry eye syndrome and corneal neovascularization, therefore affecting eyesight.</p><p><strong>Case description: </strong>Our patient, a 19-year-old man with corneal neovascularization, scarring, bilateral dry eye disease, uncontrolled HS, and other medical disorders, after a year of therapy with adalimumab failed to sufficiently control the illness, secukinumab (300 mg monthly) and concomitant oral doxycycline (100 mg twice daily) were prescribed to reduce inflammation and prevent subsequent infections. As shown by ophthalmologic findings, bilateral corneal neovascularization, stromal infiltrates, and chronic inflammation helped to explain ocular discomfort and reduced quality of life. Both eyes maintained visual acuity at 6/6 even though corneal scarring could cause future damage. Management and treatment: A multidisciplinary team under management of the patient comprised ophthalmology and dermatology doctors. Using continuous systemic treatment, management of HS flares and ocular inflammation is the ocular treatment included Tobradex, Lumify, artificial tears; more modern treatments like anti-VEGF therapy were under consideration for cases of progressive neovascularization.</p><p><strong>Conclusion: </strong>As this case shows, a multidisciplinary approach is absolutely essential when tackling HS including the eyes. Early diagnosis and tailored treatment plans allow one to improve patient outcomes, maintain visual function, and minimize repercussions. More study is needed to better grasp the pathophysiology of HS-related ocular problems and create more sensible treatment plans.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 358","pages":"31-34"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Georgian medical news","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patients with chronic inflammatory skin disease called hidradenitis suppurativa (HS), which can also produce systemic comorbidities, show ocular symptoms. Although HS has dermatological roots, if left untreated it can cause major ocular issues like dry eye syndrome and corneal neovascularization, therefore affecting eyesight.

Case description: Our patient, a 19-year-old man with corneal neovascularization, scarring, bilateral dry eye disease, uncontrolled HS, and other medical disorders, after a year of therapy with adalimumab failed to sufficiently control the illness, secukinumab (300 mg monthly) and concomitant oral doxycycline (100 mg twice daily) were prescribed to reduce inflammation and prevent subsequent infections. As shown by ophthalmologic findings, bilateral corneal neovascularization, stromal infiltrates, and chronic inflammation helped to explain ocular discomfort and reduced quality of life. Both eyes maintained visual acuity at 6/6 even though corneal scarring could cause future damage. Management and treatment: A multidisciplinary team under management of the patient comprised ophthalmology and dermatology doctors. Using continuous systemic treatment, management of HS flares and ocular inflammation is the ocular treatment included Tobradex, Lumify, artificial tears; more modern treatments like anti-VEGF therapy were under consideration for cases of progressive neovascularization.

Conclusion: As this case shows, a multidisciplinary approach is absolutely essential when tackling HS including the eyes. Early diagnosis and tailored treatment plans allow one to improve patient outcomes, maintain visual function, and minimize repercussions. More study is needed to better grasp the pathophysiology of HS-related ocular problems and create more sensible treatment plans.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Georgian medical news
Georgian medical news Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
207
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信